Related Experiment Video
Updated: May 30, 2026
05:51
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
E. C. T. And drug induced parkinsonism
B N Gangadhar1, J R Choudhary, S M Channabasavanna
1Lecturer, Department of Psychiatry, NIMHANS, Bangalore-560029.
Indian Journal of Psychiatry
|August 18, 2011
Summary
Electroconvulsive therapy (ECT) may reduce drug-induced parkinsonism symptoms in hospitalized patients. Those receiving two or more ECT sessions showed significantly lower parkinsonism scores compared to non-ECT patients.
Area of Science:
- Neuroscience
- Pharmacology
- Clinical Medicine
Background:
- Drug-induced parkinsonism is a common side effect of certain medications.
- Hospitalized patients are at risk for developing parkinsonian symptoms due to polypharmacy.
Purpose of the Study:
- To evaluate the presence and severity of drug-induced parkinsonian symptoms in hospitalized patients.
- To investigate the potential effect of electroconvulsive therapy (ECT) on drug-induced parkinsonism.
Main Methods:
- A cross-sectional study design was employed.
- Hospitalized patients were assessed for drug-induced parkinsonian symptoms.
- Patients were categorized based on whether they received two or more ECT sessions.
Main Results:
- Patients who received two or more ECTs exhibited lower scores for parkinsonism compared to those not receiving ECT.
- The patient groups were comparable on factors influencing drug-induced parkinsonism.
Conclusions:
- Electroconvulsive therapy may have a beneficial effect in reducing drug-induced parkinsonian symptoms.
- Further research is warranted to confirm the therapeutic potential of ECT for drug-induced parkinsonism.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...